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Aspirin-intolerant chronic urticaria (AICU) is a common condition among the chronic urticaria population, but the genetic mechanism is not yet 
understood. In this study, the genotypes and haplotypes of three interleukin (IL)-13 polymorphisms, −1510 A>C, −1055C>T, and Arg110Gln 
(110G>A), as well as their respective clinical phenotypes were examined to determine whether genetic variants of IL-13 play a role in AICU. 
Single-nucleotide polymorphism (SNP) genotyping was used to compare IL-13 genotype and allele frequencies among 135 patients with AICU, 
146 with aspirin-tolerant chronic urticaria (ATCU), and 430 normal controls (NC). Relationships among the AICU phenotype, atopy, and total IgE 
level were also investigated. The results failed to show a significant difference in the allele or genotype frequencies between the AICU group and 
either the ATCU or NC group (P>0.05, respectively). Haplotype analysis confirmed that there was no significant difference among the three study 
groups (P>0.05), nor was there a significant difference in atopy or total IgE level according to the three genetic polymorphisms (P>0.05, 
respectively). Our data lead to the conclusion that there is no evidence supporting genetic polymorphisms in IL-13 as a genetic risk factor for the 
development of AICU.
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INTRODUCTION
Aspirin and other non-steroidal anti-inflammatory drugs 
(NSAIDs) cause symptoms in 20–30% of patients with chronic 
urticaria (CU).
1,2 In the Korean population, 35.7% of CU pa-
tients are affected, as confirmed by oral provocation testing.
3 
Several genes are likely to be involved in the etiology and 
pathogenesis of aspirin-intolerant urticaria (AIU), including 
both the acute and chronic forms as well as intermediate phe-
notypes. The candidate genes include HLA-DRB1 *1302-
DQB1*0609,
4 ALOX5,
5 FCER1A,
6 HNMT,
7 and FCER1G.
8
The cytokine interleukin (IL)-13 is produced primarily by acti-
vated Th2 cells
9 and is thought to play a role in the mechanisms 
of several atopic conditions. IL-13 promotes B cell differentia-
tion and is capable of inducing isotype-switching in B cells, re-
sulting in the production of IgG4 and IgE.
10 Human lung mast 
cells express IL-13Ra1, and activation of these cells by the cyto-
kine for 5 days increased FceRI expression and proliferation.
11 
IL-13 maps to chromosome 5q31, which has been implicated 
in the development of asthma and atopy.
12 It is a critical effector 
in the induction and maintenance of IgE production and IgE-
mediated allergic airway responses.
13
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Analyses of IL-13 gene polymorphisms have produced vari-
ous results depending on the specific study population. For ex-
ample, genetic association studies in German
14 and Chinese 
populations have suggested a role for the IL-13 variant Arg-
110Gln in the increased IgE production and atopic sensitization 
that characterizes allergic rhinitis, whereas this allele was found 
to be associated with asthma in British and Japanese popula-
tions.
15 Previous studies have reported that AICU patients had a 
significantly higher rate of atopy than ATCU patients and nor-
mal controls, suggesting that atopy is a risk factor for AICU.
3,8 A 
study on FcER1a promoter polymorphisms found that the pro-
longed exposure of AICU patients to IgE induces the persistent 
accumulation and activation of mast cells and basophils via in-
creased surface expression of high-affinity IgE receptors.
6
To identify genetic factors in the development of AICU, we an-
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alyzed the genotypes and haplotypes of three polymorphisms 
of IL-13 to determine whether genetic variants of IL-13 play an 
important role in AICU.
MATERIALS AND METHODS
Study subjects and phenotyping
Two groups of CU patients, AICU (n=135) and ATCU (n=146), 
who were identified based on the results of n oral provocation 
test with up to 500 mg of aspirin (Rhonal; KunWha Pharmaceu-
tical Co., Seoul, Korea), were enrolled in the study, as described 
previously.
4 AICU patients who had aspirin-intolerant asthma 
(AIA) were excluded. Normal healthy controls (NC; n=430) 
with no personal or family history of allergic diseases, or aspirin 
or drug hypersensitivity were recruited from the general Korean 
population. Informed consent was obtained from all partici-
pants, and the institutional review board of Ajou University 
Hospital approved this study. Skin-prick tests were performed 
with 55 common aeroallergens (Bencard Co., West Sussex, UK), 
and atopy was defined as one or more positive reactions to 
common inhalant allergens. Total IgE concentrations were 
measured using a UniCAP system (Phadia, Uppsala, Sweden), 
according to the manufacturer’s instructions. Anti-thyroglobu-
lin levels in serum were measured using anti-Tg (B.R.A.H.M.S 
Aktiengesellschaft, Hennigsdorf, Germany) and serum anti-
microsomal antibodies with a thyroid peroxidase IgG ELISA 
(Zeus Scientific, Zierikzee, Netherlands). 
SNP identification and genotyping 
Peripheral blood samples from 40 healthy Korean volunteers 
were used to identify single nucleotide polymorphisms (SNPs). 
Genomic DNA was prepared from the blood samples using a 
Puregene DNA purification kit (Gentra, Minneapolis, MN, 
USA), according to the manufacturer’s protocol. 
The IL-13 gene was examined for SNPs using an ABI Prism 
3100 DNA analyzer (Applied Biosystems, Foster City, CA, USA). 
Three polymorphisms of IL-13, −1510 A>C, −1055C>T, and Arg-
110Gln (110G>A), were genotyped using a primer-exten  sion 
method and a SNAPshot ddNTP primer-extension kit (Applied 
Biosystems). The primers used were: for IL-13 -1510A>C, forward 
(F) 5’-TGTGGGAGATGCCGTGGG-3’ , reverse (R) 5’-TCT-
GACTCCCAGAAGTCTGC-3’ , and extension 5’-TACAGATTAG-
GAAACAGGCCCGTAG-3’; for IL-13−1055C>T, (F) 5’-AGAGA-
GGGTGGGAATGAC-3’ , (R) 5’-CCAGTCTCTGCAGGATCA-3’ , 
and extension 5’-TGTCGCCTTTTCCTGCTCTTCCCTC-3’; and 
for IL-13 110G>A, (F) 5’-AGTTTGTAAAGGACCTGCTCTTAC-3’ , 
(R) 5’-TCAGGTCCTGTCTCTGCAA-3’ , and extension 5’-TTA-
AAGAAACTTTTTCGCGAGGGAC-3’ .
Statistical analysis
Chi-squared tests were used to detect significant departures 
in genotype frequency from the Hardy-Weinberg equilibrium 
at each SNP. Haplotypes of IL-13 were analyzed using Haplo-
view v2.0, based on the expectation maximization algorithm. 
Differences in the mean values of phenotypic characteristics 
among AICU patients were compared using the chi-squared 
test, or Fisher’s exact test and independent t-test. Continuous 
variables that did not have a normal distribution, such as the 
levels of serum total IgE, were log-transformed. Differences in 
genotype frequency between groups were examined with the 
chi-squared test, and three logical regression models (co-domi-
nant, dominant, recessive) were used after accounting for age 
and gender covariates. The level of statistical significance was 
set at P<0.05. SPSS 12.0 for Windows software (SPSS Inc., Chi-
cago, IL, USA) was used for the statistical analyses.
 
RESULTS
In our study, genetic associations among three genetic poly-
morphisms of IL-13, −1510A>C, −1055C>T, and Arg110Gln 
(110G>A), and the three study groups (AICU, ATCU, and NC) 
were examined. No significant association was detected be-
tween the IL-13 polymorphisms and susceptibility to AICU (P> 
0.05). 
Significant differences in AICU phenotypes, based on the 
presence of atopy and log serum total IgE levels, were found 
between the AICU, ATCU, and NC groups (P<0.001, respective-
ly) (Table 1). However, there were no significant differences be-
Table 1. Clinical characteristics of study subjects
AICU ATCU NC
P value
AICU vs ATCU AICU vs NC ATCU vs NC
Sex (male/total) 66/135 (48.9%) 68/146 (46.6%) 206/430 (47.9%) 0.394 0.844 0.428
Atopy (presence/total) 97/134 (72.4%) 71/145 (49.0%) 32/277 (11.6%) <0.001 <0.001 <0.001
Log (serum total IgE [IU/mL]/number of subjects) 5.17±1.07/117 4.67±1.11/137 3.63±1.34 <0.001 <0.001 <0.001
Anti-thyroglobulin antibody (positive/total) 12/94 (12.8%) 23/130 (17.7%) NA 0.355 NA NA
Antimicrosomal antibody (positive/total) 7/94 (7.4%) 20/130 (15.4%) NA 0.096 NA NA
Values in bold indicate significant P value. The value was presented as means±S.D.
AICU, aspirin-intolerant chronic urticaria; NC, normal controls; ATCU, aspirin-tolerant chronic urticaria; NA, not applicable.Allergy Asthma Immunol Res. 2009 October;1(1):36-40.  doi: 10.4168/aair.2009.1.1.36
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tween the two CU groups with respect to allele and genotype 
frequencies (P>0.05) (Table 2). Furthermore, the three poly-
morphisms of IL-13 were not in linkage disequilibrium.
Using Haploview 2.0 and the expectation maximization algo-
rithm, five common haplotypes were constructed: ht1 (ACG), 
ht2 (CTA), ht3 (ACA), ht4 (CCG), and ht5 (CTG). Haplotype 
analysis further confirmed that there were no significant differ-
ences among the three study groups (P>0.05) (data not shown). 
The relationship between the investigated genotypes of the 
three polymorphisms and AICU phenotype was not signifi-
cantly different for atopy (Table 4) or total IgE (Table 3) accord-
ing to the three different methods of analysis (P>0.05). 
DISCUSSION
This study evaluated three AICU-susceptibility loci in the IL-
13 gene: two SNPs in the promoter region (−1510 A>C and 
−1055C>T) and one nonsynonymous SNP (Arg110Gln, 110G 
>A). In a case control study, we evaluated the three polymor-
phisms for evidence of association with AICU and related phe-
notypes. Based on the results, no evidence was found to sup-
port a significant association between these three SNPs and the 
diagnosis of AICU.
The cytokines IL-13 and IL-4 share biological properties such 
as isotype switching to IgE and expression of endothelial cell 
adhesion molecules.
16 Accordingly, it was reasonable to pro-
pose that in chronic urticaria, IL-13 increases mast cell FceR1 
expression and mediator release,
17 leading to the development 
of hives and the enhancement of cutaneous inflammation. In a 
previous report, patients with more frequent itch were found to 
have higher cytokine levels, suggesting that IL-13 may serve as 
a serological marker of disease activity.
18
Owing to the lack of previously published data on IL-13 SNPs 
in patients with AICU, our results cannot be compared directly 
with others. However, several studies showed a linkage be-
tween IL-13 and a high serum total IgE level,
19,20 including an 
association of IL-13 Arg110Gln with serum IgE levels in patients 
with asthma
15,21 and atopic dermatitis.
22 IL-13 variants have 
Table 2. Allele and genotype frequencies of aspirin-intolerant chronic urticaria
Genotype AICU (n=135) ATCU (n=146) NC (n=430)
P value
AICU vs ATCU AICU vs NC ATCU vs NC
-1510A>C AA
AC
CC
q
68 (50.4%)
58 (43.0%)
9 (6.7%)
0.281
72 (49.3%)
61 (41.8%)
13 (8.9%)
0.298
235 (54.7%)
156 (36.3%)
39 (9.1%)
0.272
0.728
0.438
0.983
0.438
0.799
0.42
0.438
0.42
0.37
0.858
0.286
0.858
-1055C>T CC
CT
TT
q
91 (67.4%)
41 (30.4%)
3 (2.2%)
0.174
103 (70.5%)
39 (26.7%)
4 (2.7%)
0.161
295 (68.6%)
112 (26.0%)
23 (5.3%)
0.184
0.514
0.944
0.447
0.944
0.692
0.155
0.864
0.155
0.438
0.299
0.632
0.299
Arg110Gln (110 G>A) GG
GA
AA
q
66 (48.9%)
52 (38.5%)
17 (12.6%)
0.319
70 (47.9%)
59 (40.4%)
174 (11.6%)
0.318
17 (47.9%)
17 (40.5%)
50 (11.6%)
0.328
0.848
0.652
0.974
0.652
1
0.735
0.827
0.735
0.836
0.858
0.867
0.858
Each P value was calculated with co-dominant, dominant, and recessive models. Logistic regression analysis was applied to control for age and sex as covari-
ables. q; Minor allele frequency. 
AICU, aspirin-intolerant chronic urticaria; NC, normal controls; ATCU, aspirin-tolerant chronic urticaria; n, number of patients.
Table 3. Comparison of the log total IgE according to the genotype of IL-13 in 
aspirin-intolerant chronic urticaria
SNPs AA vs CC AA+AC vs CC AA vs AC+CC
-1510A>C
 
  P value
5.14±1.17/56
5.10±1.41/8
0.93
5.17±1.05/109
5.10±1.41/8
0.863
5.14±1.17/56
5.19±0.99/61
0.819
-1055C>T
  
  P value
5.12±1.15/78
5.08±1.62/3
0.954
5.17±1.07/114
5.08±1.62/3
0.888
5.12±1.15/78
5.26±0.91/39
0.502
Arg110Gln (110G>A)
  
  P value
5.08±1.13/59
5.36±0.93/15
0.372
5.14±1.09/102
5.36±0.93/15
0.452
5.08±1.13/59
5.26±1.02/58
0.373
The value was presented as means±S.D./number of patients.
Table 4. Comparison of the atopy (presence/total) according to the geno-
type of IL-13 in aspirin-intolerant chronic urticaria
SNPs AA vs CC AA+AC vs CC AA vs AC+CC
-1510A>C
  
  P value
50/68 (73.5%)
    6/9 (66.7%)
0.698
91/125 (72.8%)
6/9 (66.7%)
0.707
50/68 (73.5%)
47/66 (71.2%)
0.848
-1055C>T
  
  P value
69/91 (75.8%)
2/3 (66.7%)
1
95/131 (72.5%)
2/3 (66.7%)
1
69/91 (75.8%)
28/43 (65.1%)
0.218
Arg110Gln (110G>A)
  P value
51/66 (77.3%)
11/16 (68.8%)
0.522
86/118 (72.9%)
11/16 (68.8%)
0.768
51/66 (77.3%)
46/68 (67.6%)
0.249Allergy Asthma Immunol Res. 2009 October;1(1):36-40.  doi: 10.4168/aair.2009.1.1.36
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been associated with airway responsiveness
23 and with eosino-
phil count.
24 Recently, IL-13 Arg110Gln was reported to be sig-
nificantly associated with reduced lung function in Korean 
children and adolescents.
25 Nevertheless, we found no signifi-
cant association of either of the promoter SNPs or the coding 
SNP with AICU traits, including serum total IgE and atopy. Our 
findings indicate that a genetic variation in the form of any of 
the three SNPs at the IL-13 locus is not likely to be involved in 
the development of AICU.
This result is consistent with an earlier report showing that 
there was no relationship between the coding SNP and allergic 
rhinitis induced by artemisia pollen and/or DerpI in a Chinese 
population. Marginal significance was found for atopy-related 
phenotypes associated with the Arg110Gln variant and in vitro 
specific IgE responses to common inhalant allergens.
26 In our 
previous study, two SNPs, at FceR1b E237G and FceR1g, were 
associated with atopy in AICU patients, but not in ATCU pa-
tients, and were proposed to explain the increased release of 
histamine from basophils and subsequent development of the 
AICU phenotype.
8 Furthermore, other studies have noted a sig-
nificant association of the FceR1b-109T>C and FceR1b E237G 
polymorphisms with serum IgE levels in asthmatic patients,
27,28 
and the FceR1a −344C>T polymorphism in AICU.
6 However, in 
our study, IL-13 genetic polymorphisms were not related to ei-
ther atopy or total IgE levels in AICU patients, implying that 
neither the two SNPs in the functional promoter nor the SNP in 
the coding sequence contribute significantly to AICU suscepti-
bility. This is the first detailed investigation showing the ab-
sence of a genetic association between IL-13 and AICU and its 
phenotypes, i.e., serum total IgE and atopy. There is no evi-
dence that these three SNPs are associated with AICU; instead, 
SNPs of IL-13 may confer a greater susceptibility to asthma or 
other inflammatory diseases.
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